Introduction

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

E v v infection increases the risk of multiple sclerosis 32 fold. A phase one trial of an e v v vaccine is under way, although it will be years before large trials can shed light on wheether vaccines forestall m s. Researchers are more interested than ever in what happens months and years after a viral infection. Two years into the corona virus pandemic, huge numbers face lasting symptoms after their initial infection with sas cove too.

Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.

These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.

This is an audio version of our Feature: The quest to prevent MS — and understand other post-viral diseases.

Hosted on Acast. See acast.com/privacy for more information.